中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
15期
50-51
,共2页
抗结核药物%用药金额%用药频度%日均费用
抗結覈藥物%用藥金額%用藥頻度%日均費用
항결핵약물%용약금액%용약빈도%일균비용
antituberculosis drugs%consumption sum%defined daily doses%defined daily cost
目的:分析武汉地区2009年至2013年抗结核药物的应用情况,为临床合理用药提供参考。方法对2009年至2013年武汉地区34家入网医院抗结核药物的用药金额、用药频度(DDDs)、日均费用(DDC)进行统计分析。结果武汉地区年抗结核用药金额及 DDDs逐年增加,一线抗结核药物仍占主导地位,二线抗结核药物用量虽呈逐年增加趋势,但其比例仍小于一线抗结核药。经典抗结核药物DDDs 仍居主导地位,新的抗结核药物也在逐渐扩大应用。结论武汉地区医院抗结核药物临床应用基本合理,也反映了目前结核病治疗的发展趋势,但中成药抗结核病的疗效仍有待评估。
目的:分析武漢地區2009年至2013年抗結覈藥物的應用情況,為臨床閤理用藥提供參攷。方法對2009年至2013年武漢地區34傢入網醫院抗結覈藥物的用藥金額、用藥頻度(DDDs)、日均費用(DDC)進行統計分析。結果武漢地區年抗結覈用藥金額及 DDDs逐年增加,一線抗結覈藥物仍佔主導地位,二線抗結覈藥物用量雖呈逐年增加趨勢,但其比例仍小于一線抗結覈藥。經典抗結覈藥物DDDs 仍居主導地位,新的抗結覈藥物也在逐漸擴大應用。結論武漢地區醫院抗結覈藥物臨床應用基本閤理,也反映瞭目前結覈病治療的髮展趨勢,但中成藥抗結覈病的療效仍有待評估。
목적:분석무한지구2009년지2013년항결핵약물적응용정황,위림상합리용약제공삼고。방법대2009년지2013년무한지구34가입망의원항결핵약물적용약금액、용약빈도(DDDs)、일균비용(DDC)진행통계분석。결과무한지구년항결핵용약금액급 DDDs축년증가,일선항결핵약물잉점주도지위,이선항결핵약물용량수정축년증가추세,단기비례잉소우일선항결핵약。경전항결핵약물DDDs 잉거주도지위,신적항결핵약물야재축점확대응용。결론무한지구의원항결핵약물림상응용기본합리,야반영료목전결핵병치료적발전추세,단중성약항결핵병적료효잉유대평고。
Objective To analyze the current applications and trends of antituberculosis drugs in Wuhan area from 2009 - 2013. Methods Using the analytical method of the consumption sum, the Defined Daily Dose (DDDs), the DDC in 34 hospitals of Wuhan area during the period 2009 - 2013 was analyzed statistically. Results The consumption sum and the frequency of drug use of antitu-berculosis drugs increased year by year. The first - line antituberculosis drugs were still the preferred drugs, and the ratio of second -line antituberculosis drugs was less than first - line ones, although there was a rising tendency of the consumption of second - line anti-tuberculosis. The consumption of the new antituberculosis drugs increased in these five years. Conclusion The utilization of antitubercu-losis drugs are basically reasonable, and reflect the trends of tuberculosis treatment. But the use of Chinese medicines still needs further evaluation.